AlcaSynn Pharmaceuticals GmbH
AlcaSynn Pharmaceuticals GmbH (APG) is a privately held drug development company, engaged in the preclinical and clinical development of morphinan opioids. The company holds material experience in the medicinal chemistry of morphinans. It has developed a broad portfolio of innovative drug candidates targeting a variety of different medicinal indications. The company focuses on the development of drugs with target molecules as opioid receptors. AlcaSynn distributes product licenses for the development and marketing of therapeutic medication, as well as services in the field of drug development. Its products are also used to treat rheumatoid arthritis, obstruction, intestinal itching, inflammatory skin diseases and stomach ulcers. AlcaSynn is a subsidiary of Sanochemia Pharmazeutika AG, Vienna. The company is headquartered in Innsbruck, Austria.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

